Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal
The latent HIV reservoir is a major barrier to HIV cure. Combining latency reversal agents (LRAs) with differing mechanisms of action such as AZD5582, a non-canonical NF-kB activator, and I-BET151, a bromodomain inhibitor is appealing toward inducing HIV-1 reactivation. However, even this LRA combin...
Saved in:
| Main Authors: | Carley N Gray, Manickam Ashokkumar, Derek H Janssens, Jennifer L Kirchherr, Brigitte Allard, Emily Hsieh, Terry L Hafer, Nancie M Archin, Edward P Browne, Michael Emerman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-04-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/103064 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency.
by: Manickam Ashokkumar, et al.
Published: (2025-04-01) -
NSC95397 Is a Novel HIV-1 Latency-Reversing Agent
by: Randilea Nichols Doyle, et al.
Published: (2024-11-01) -
Latency Reversing Agents and the Road to an HIV Cure
by: Louis Tioka, et al.
Published: (2025-02-01) -
Effects of aging on regular and express latencies of vergence
by: Qing Yang, et al.
Published: (2009-01-01) -
HIV Tat as a latency reversing agent: turning the tables on viral persistence
by: Bridget M. Fisher, et al.
Published: (2025-04-01)